Chapter 14. Depression
1. Unützer J, Klap R, Sturm R, Young AS, Marmon T, Shatkin J, Wells KB. Mental disorders and the use of alternative medicine: results from a national survey. Am J Psychiatry. 2000 Nov;157(11):1851-7
2. Druss BG, Rosenheck RA. Use of practitioner-based complementary therapies by persons reporting mental conditions in the United States. Arch Gen Psychiatry. 2000 Jul;57(7):708-14.
3. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998 Nov 11;280(18):1569-75.
4. Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay MI MI, Eisenberg DM. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2001 Feb;158(2):289-94.
5. Knaudt PR, Connor KM, Weisler RH, Churchill LE, Davidson JR. Alternative therapy use by psychiatric outpatients. J Nerv Ment Dis. 1999 Nov;187(11):692-5. No abstract available.
6. Rickhi B, Quan H, Moritz S, Stuart HL, Arboleda-Flórez J. Mental disorders and reasons for using complementary therapy. Can J Psychiatry. 2003 Aug; 48(7):475-9.
7. Vincent C, Furnham A. Why do patients turn to complementary medicine? An empirical study. Br J Clin Psychol. 1996 Feb;35 ( Pt 1):37-48.
8. Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998 May 20;279(19):1548-53.
9. Miresco MJ, Kirmayer LJ. The persistence of mind-brain dualism in psychiatric reasoning about clinical scenarios. Am J Psychiatry. 2006 May;163(5):913-8.
10. Chodoff P. The medicalization of the human condition. Psychiatr Serv. 2002 May;53(5):627-8.
11. Epstein RM, Shields CG, Franks P, Meldrum SC, Feldman M, Kravitz RL. Exploring and validating patient concerns: relation to prescribing for depression. Ann Fam Med. 2007 Jan-Feb;5(1):21-8.
12. Zollman C, Vickers A. ABC of complementary medicine. Complementary medicine and the patient. BMJ. 1999 Dec 4;319(7223):1486-9. Review. No abstract available
13. Rush AJ. Limitations in efficacy of antidepressant monotherapy. J Clin Psychiatry.2007;68 Suppl 10:8-10.
14. Zajecka JM. Treating depression to remission. J Clin Psychiatry. 2003;64 Suppl 15:7-12.
15. Thase ME, Jindal RD. Combining psychotherapy and psychopharmacology for treatment of mental disorders. In: Lambert MJ, editor. Bergin and Garfield’s Handbook of psychotherapy and behavior change. 5th ed. New York: John Wiley and Sons Inc; 2004. p 743–66.
16. Ablon JS, Jones EE. Validity of controlled cinical trials of psychotherapy: findings from the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 2002 May;159(5):775-83.
17. Dwight-Johnson M, Sherbourne CD, Liao D, Wells KB. Treatment preferences among depressed primary care patients. J Gen Intern Med. 2000 Aug;15(8):527-34.
18. Hirschfeld R, Keller M, Panico S, Arons B, Barlow D, Davidoff F, and others. The National Depressive and Manic-Depressive Association consensus statement on undertreatment of depression. JAMA 1997;277:333–40.
19. Van Voorhees BW, Cooper LA, Rost KM, Nutting P, Rubenstein LV, Meredith L, Wang NY, Ford DE. Primary care patients with depression are less accepting of treatment than those seen by mental health specialists. J Gen Intern Med. 2003 Dec;18(12):991-1000.
20. Edlund MJ, Wang PS, Berglund PA, Katz SJ, Lin E, Kessler RC. Dropping out of mental health treatment: patterns and predictors among epidemiological survey respondents in the United States and Ontario. Am J Psychiatry. 2002 May;159(5):845-51.
21. Lyons D, McLoughlin DM. Recent advances: Psychiatry. BMJ. 2001 Nov 24; 323(7323):1228-31.
22. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Raue P, Friedman SJ, Meyers BS. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry. 2001 Mar;158(3):479-81.
23. Elkin I, Gibbons RD, Shea MT, Sotsky SM, Watkins JT, Pilkonis PA, Hedeker D. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1995 Oct;63(5):841-7.
24. Rush AJ, Thase ME. Psychotherapies for depressive disorders: a review. In: Sartorius N, ed. WPA Series. Evidence and Experience in Psychiatry: Volume 1. Depressive Disorders. Chichester, UK: John Wiley and Sons; 1999:161-206.
25. Mental Health: A Report of the Surgeon General. 1999. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health, Rockville, MD.
26. Wierzbicki, M., and Pekarik, G. (1993). A meta-analysis of outpatient therapy dropout studies. Professional Psychology: Research and Practice, 24, 190-195.
27. Mohl PC, Martinez D, Ticknor C, Huang M, Cordell L. Early dropouts from psychotherapy. J Nerv Ment Dis. 1991 Aug;179 (8):478-81.
28. Piper, W.E., Ogrodniczuk, J.S., Joyce, A.S., McCallum, M., Rosie, J.S., O’Kelly, J.G., & Steinberg, P.I. (1999). Prediction of dropping out in time-limited, interpretive individual psychotherapy. Psychotherapy, 36, 114-122.
29. Wong EC, Kim BS, Zane NW, Kim IJ, Huang JS. Examining culturally based variables associated with ethnicity: influences on credibility perceptions of empirically supported interventions. Cultur Divers Ethnic Minor Psychol. 2003 Feb;9(1):88-96.
30. Wen-Shing Tseng, Jon Streltzer, Editors Culture and Psychotherapy: A Guide to Clinical Practice. 2001 American Psychiatric Press, Inc.
31. Kozuki Y, Kennedy MG. Cultural incommensurability in psychodynamic psychotherapy in Western and Japanese traditions. J Nurs Scholarsh. 2004;36(1):30-8.
32. Ogrodniczuk JS, Joyce AS, Piper WE. Strategies for reducing patient-initiated premature termination of psychotherapy. Harv Rev Psychiatry. 2005 Mar-Apr;13(2):57-70.
33. Wang JL, Patten SB, Russell ML. Alternative medicine use by individuals with major depression. Can J Psychiatry. 2001 Aug;46(6):528-33
34. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Alt Ther Health Med. 2005 Jan-Feb;11(1):42-9.
35. Saper RB, Eisenberg DM, Davis RB, Culpepper L, Phillips RS. Prevalence and patterns of adult yoga use in the United States: results of a national survey. Alt Ther Health Med. 2004 Mar-Apr;10(2):44-9.
36. Pilkington K, Kirkwood G, Rampes H, Richardson J. Yoga for depression: the research evidence. J Affect Disord. 2005 Dec;89(1-3):13-24.
37. Janakiramaiah N, Gangadhar BN et al. Antidepressant efficacy of sudarshan kriya yoga (SKY ) in melancholia: a randomized comparison with ECT and imipramine. Journal of Affective Disorders, 2000; 57: 255-259.
38. Rohini V, Pandey RS, Janakiramaiah N, Gangadhar BN, Vedamurthachar A. A comparative study of full and partial Sudarshan Kriya Yoga in major depressive disorder. NIMHANS Journal (2000) 18: 53-57
39. Broota A, Dhir R. Efficacy of two relaxation techniques in depression. J Pers Clin Stud 1990;6:83-90.
40. Khumar SS, Kaur P, Kaur MS. Effectiveness of Shavasana on depression among university students. Indian J Clin Psych 1993;20(2):82-87.
41. Woolery A, Myers H, Sternlieb B, Zeltzer L. A yoga intervention for young adults with elevated symptoms of depression. Altern Ther Health Med. 2004 Mar-Apr;10(2):60-3.
42. Jayadevappa R, Johnson JC, Bloom BS, Nidich S, Desai S, Chhatre S, Raziano DB, Schneider R. Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study. Ethn Dis. 2007 Winter;17(1):72-7.
43. Goodale, I. L., Domar, A. D., & Benson, H. (1990). Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstetrics & Gynecology 75(4):649-55, 1990 Apr.
44. Irvin, J. H., Domar, A. D., Clark, C., Zuttermeister, P. C., & Friedman, R. (1996). The effects of relaxation response training on menopausal symptoms. Journal of Psychosomatic Obstetrics & Gynecology 17(4):202-7, 1996 Dec.
45. Speca, M., Carlson, L. E., Goodey, E., & Angen, M. (2000). A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosomatic Medicine, 62(5), 613-622.
46. Sharma VK, Das S, Mondal S, Goswampi U, Gandhi A. Effect of Sahaj Yoga on depressive disorders. Indian J Physiol Pharmacol. 2005 Oct Dec; 49(4):462-8.
47. Coelho HF, Canter PH, Ernst E. Mindfulness-based cognitive therapy: evaluating current evidence and informing future research. J Consult Clin Psychol. 2007 Dec;75(6):1000-5
48. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000 Aug;68(4):615-23
49. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol. 2004 Feb;72(1):31-40.
50. Tsang HW, Fung KM, Chan AS, Lee G, Chan F. Effect of a qigong exercise programme on elderly with depression. Int J Geriatr Psychiatry. 2006 Sep;21(9):890-7.
51. Chou KL, Lee PW, Yu EC, Macfarlane D, Cheng YH, Chan SS, Chi I. Effect of Tai Chi on depressive symptoms amongst Chinese older patients with depressive disorders: a randomized clinical trial. Int J Geriatr Psychiatry. 2004 Nov;19(11):1105-7
52. Smith CA, Hay PP. Acupuncture for depression. Cochrane Database Syst Rev. 2005 Apr 18;(2): CD004046.
53. Mukaino Y, Park J, White A, Ernst E.The effectiveness of acupuncture for depression--a systematic review of randomised controlled trials. Acupunct Med. 2005 Jun;23(2):70-6.
54. Leo RJ, Ligot JS Jr. A systematic review of randomized controlled trials of acupuncture in the treatment of depression. J Affect Disord. 2007 Jan;97(1-3):13-22.
55. Quah-Smith JI, Tang WM, Russell J. Laser acupuncture for mild to moderate depression in a primary care setting--a randomised controlled trial. Acupunct Med. 2005 Sep;23(3):103-11.
56. Moyer CA, Rounds J, Hannum JW. A meta-analysis of massage therapy research. Psychol Bull. 2004 Jan;130(1):3-18.
57. Coelho HF, Boddy K, Ernst E. Massage therapy for the treatment of depression: a systematic review. International Journal of Clinical Practice 2008; 62 (2), 325–333
58. Field T, Grizzle N, Scafidi F, Schanberg S.Massage and relaxation therapies’ effects on depressed adolescent mothers. Adolescence. 1996 Winter;31(124):903-11
59. Field T, Diego MA, Hernandez-Reif M, Schanberg S, Kuhn C. Massage therapy effects on depressed pregnant women. J Psychosom Obstet Gynaecol. 2004 Jun;25(2):115-22
60. Stetter F, Kupper S. Autogenic training: a meta-analysis of clinical outcome studies. Appl Psychophysiol Biofeedback, 2002 Mar;27(1):45-98.
61. Stiefel F, Stagno D. Management of insomnia in patients with chronic pain conditions. CNS Drugs. 2004;18(5):285-96.
62. Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK; Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care. The treatment of depression in cancer patients: a systematic review. Support Care Cancer. 2007 Feb;15(2):123-36
63. McLean PD, Hakstian AR. Clinical depression: comparative efficacy of outpatient treatments. J Consult Clin Psychol. 1979 Oct;47(5):818-36
64. Murphy GE, Carney RM, Knesevich MA, Wetzel RD, Whitworth P. Cognitive behavior therapy, relaxation training, and tricyclic antidepressant medication in the treatment of depression. Psychological Reports. Vol 77(2), Oct 1995, pp. 403-420
65. Bowers WA.Treatment of depressed in-patients. Cognitive therapy plus medication, relaxation plus medication, and medication alone. Br J Psychiatry. 1990 Jan;156:73-8.
66. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005 Apr;162(4):656-62.
67. Tuunainen A, Kripke DF, Endo T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev. 2004;(2):CD004050
68. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005 Jan;28(1):1-8
69. Lawlor, Debbie A. and Stephen W. Hopker. The Effectiveness of Exercise as an Intervention in the Management of Depression: Systematic Review and Meta-Regression Analysis of Randomised Controlled Trials. British Medical Journal 322: 1-8 (March 31, 2002).
70. Blumenthal, James A. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosomatic medicine [0033-3174] yr: 2007 vol:69 iss:7 pg:587 –96
71. Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U. Effectiveness of St John’s wort in major depression: a randomized controlled trial.
72. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002 Apr 10;287(14):1807-14.
73. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John’s wort for depression--an overview and meta-analysis of randomised clinical trials. BMJ. 1996 Aug 3;313(7052):253-8
74. Williams JW Jr, Mulrow CD, Chiquette E, Noël PH, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med. 2000 May 2;132(9):743-56.
75. Whiskey E, Werneke U, Taylor D. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. Int Clin Psychopharmacol. 2001 Sep;16(5):239-52. Review.
76. Werneke U, Horn O, Taylor DM. How effective is St John’s wort? The evidence revisited. J Clin Psychiatry. 2004 May;65(5):611-7
77. Röder C, Schaefer M, Leucht S. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John’s Wort] Fortschr Neurol Psychiatr. 2004 Jun;72(6):330-43. German.
78. Linde K, Mulrow CD, Berner M, Egger M. St John’s wort for depression. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000448. Review.
79. Szegedi A, Kohnen R, Dienel A, Kieser M. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John’s wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ. 2005 Mar 5;330(7490):503.
80. Bressa GM. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl. 1994;154:7-14
81. Delle Chiaie R, Pancheri P, Scapicchio P. Delle Chiaie R, Pancheri P, Scapicchio P. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr. 2002 Nov; 76(5):1172S-6S.
82. S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease. Summary, Evidence Report/Technology Assessment: Number 64. AHRQ Publication No. 02-E033, August 2002. Agency for Healthcare Research and Quality, Rockville MD. www.ahrq.gov/clinic/epcsums/samesum.htm
83. Mischoulon D. Update and critique of natural remedies as antidepressant treatments. Psychiatr Clin North Am. 2007 Mar;30(1):51-68.
84. Coppen A, Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol. 2005 Jan;19(1):59-65
85. Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH. Enhancement of recoveryfrom psychiatric illness by methylfolate. Lancet. 1990 Aug 18;336(8712):392-5.
86. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord. 2000 Nov; 60(2):121-30.
87. Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J Psychiatry. 2006 Jun;163(6):969-78. Review.
88. Nemets B, Stahl ZM, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159: 477–9.
89. Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003;13(4):267–71.
90. Marangell LB, Martinez JM, Zboyan HA, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003;160(5):996–8
91. Silvers KM, Woolley CC, Hamilton FC, et al. Randomized double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 2005;72:211–8.
92. Basti A, Moshiri E, Noorbala AA, et al. Comparison of petal of Crocus sativus L and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 14.
93. Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther. 2006 Mar;109(3):325-38.
94. Taylor MJ, Wilder H, Bhagwagar Z, Geddes J. Inositol for depressive disorders. Cochrane Database Syst Rev. 2004;(2): CD004049.
| The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. |